Loading…
Loading…
EQUITY / NASDAQ · XNMS
SBC Medical Group Holdings Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗5.09 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 5.09 USD · Volume 167,083
64 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 49,188,068 USD | 43,358,847 USD | +13.44% |
| Operating profit | 18,960,550 USD | 14,554,192 USD | +30.28% |
| Net income | 10,692,822 USD | 2,458,240 USD | +334.98% |
| Cash and cash equivalents | 184,311,213 USD | — | — |
| Total liabilities | 126,743,880 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 184,311,213 USD | — | — | 163,773,838 USD | 163,773,838 USD | 127,431,318 USD | — | — |
| Gross profitIncome statement | 35,977,316 USD | 66,324,050 USD | — | — | 127,283,722 USD | 30,611,487 USD | 98,355,148 USD | 30,010,577 USD |
| Net incomeIncome statement | 10,692,822 USD | 22,000,893 USD | 11,329,020 USD | — | 50,985,613 USD | 12,824,636 USD | 36,785,322 USD | 2,458,240 USD |
| Operating profitIncome statement | 18,960,550 USD | 36,680,565 USD | — | — | 67,486,398 USD | 15,881,240 USD | 54,637,506 USD | 14,554,192 USD |
| RevenueIncome statement | 49,188,068 USD | 92,248,630 USD | — | — | 173,607,489 USD | 43,353,235 USD | 134,040,783 USD | 43,358,847 USD |
| Total assetsBalance sheet | 406,659,022 USD | — | — | 380,447,946 USD | 380,447,946 USD | 321,363,085 USD | — | — |
| Total equityBalance sheet | 263,836,341 USD | — | 270,384,177 USD | 248,282,196 USD | 248,282,196 USD | 247,988,292 USD | — | 244,652,571 USD |
| Total liabilitiesBalance sheet | 126,743,880 USD | — | — | 117,143,240 USD | 117,143,240 USD | 73,303,884 USD | — | — |
| Capital expendituresCash flow statement | — | 209,391 USD | — | — | 1,401,012 USD | — | 603,484 USD | — |
| Financing cash flowCash flow statement | — | -3,803,472 USD | — | — | 38,292,183 USD | — | 18,470,001 USD | — |
| Investing cash flowCash flow statement | — | 37,206 USD | — | — | -20,971,552 USD | — | 3,239,523 USD | — |
| Operating cash flowCash flow statement | — | 31,741,248 USD | — | — | 24,668,496 USD | — | -27,295,426 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/27/2026 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.